Biocon enters into agreement to acquire stake in HRTPL

23 Nov 2020 Evaluate

Biocon has entered into an agreement for acquisition of 26% equity stake on a fully diluted basis in Hinduja Renewables Two (HRTPL), a special purpose vehicle formed for the purpose of power generation and developing a captive power plant as per Electricity laws. HRTPL was incorporated on September 25, 2020, which will engage in the business of power generation and will develop a 19.77 MW wind power plant (captive) at Raichur District of Karnataka.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.

Biocon Share Price

363.95 -2.45 (-0.67%)
27-Jan-2026 12:05 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1633.20
Dr. Reddys Lab 1242.00
Cipla 1308.50
Zydus Lifesciences 891.30
Lupin 2148.90
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×